Calendar PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Market Closed - Euronext Paris 11:35:05 2024-05-17 am EDT 5-day change 1st Jan Change
3.055 EUR +0.16% Intraday chart for PHAXIAM Therapeutics S.A. +3.56% -33.59%

Chart calendar PHAXIAM Therapeutics S.A.

d61a8dfdc85703.TW538-LZacpL9dWxHG2EXUsWs1txTTgki3v-x7HccXQ.Ll8nqYjpGKQ8wObZTyj0KHln1AsJPU5M6hyw_4OTGzIGWxiB1I0__xSt7Q~30a87ffc364d8c06fb529423f3a6ee8f

Upcoming events on PHAXIAM Therapeutics S.A.

2024-06-27 Annual General Meeting
2024-09-24 Q2 2024 Earnings Release After hours
2024-09-26 08:30 am Q2 2024 Earnings Call
2024-11-12 Q3 2024 Earnings Release After hours
2024-11-14 08:30 am Q3 2024 Earnings Call
2025-03-18 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)
2025-09-17 Q2 2025 Earnings Release (Projected)
2025-11-11 Q3 2025 Earnings Release (Projected)

Past events on PHAXIAM Therapeutics S.A.

2024-05-16 08:30 am Q1 2024 Earnings Call
2024-05-14 Q1 2024 Earnings Release After hours
2024-03-21 09:30 am Q4 2023 Earnings Call
2024-03-20 01:00 pm Q4 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
5,28
5,46
-3.25%
3,72
7,69
-51.63%
4,18
7,95
-47.4%
31,0
9,20
236.93%
0,00
0,00
-

1,05

EBITDA
Million EUR
Released
Forecast
Spread
-59,9
-51,2
-16.99%
-63,8
-32,6
-95.83%
-51,1
-70,4
27.36%
1,82
-52,6
103.47%
0,00
-25,3
-

-17,5

EBIT
Million EUR
Released
Forecast
Spread
-64,1
-58,0
-10.4%
-68,8
-62,4
-10.24%
-56,5
-62,9
10.12%
-2,80
-52,6
94.68%
-23,7
-25,9
8.65%

1,00

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-62,7
-57,7
-8.52%
-73,3
-63,7
-15.06%
-53,8
-57,3
6.18%
0,00
0,00
-
0,00
0,00
-

0,00

Net income
Million EUR
Released
Forecast
Spread
-62,7
-57,5
-8.92%
-73,3
-63,7
-15.06%
-53,8
-62,1
13.41%
-0,23
-52,8
99.57%
-23,5
-26,0
9.66%

-0,90

EPS
EUR
Released
Forecast
Spread
-34,9
-29,6
-17.73%
-39,9
-29,1
-37.11%
-22,7
-39,0
41.79%
-0,10
-22,3
99.55%
0,00
-4,28
-

-1,41

Announcement Date16/03/2008/03/2127/04/2222/03/2320/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q4 2022 Q1 2022 S1 2022 Q3
Net sales
Million EUR
Released
Forecast
Spread
2,32
2,60
-10.85%
1,85
1,60
15.56%
1,87
1,90
-1.63%
2,27
1,10
106.36%
0,96
1,25
-23.2%
0,54
1,75
-69.2%



0,47


EBITDA
Million EUR
Released
Forecast
Spread
-30,7
-27,1
-13.31%
-33,6
-28,5
-18%
-31,0
-31,3
1.02%
-26,5
-31,0
14.61%












EBIT
Million EUR
Released
Forecast
Spread
-33,8
-28,4
-19.12%
-35,4
-30,2
-17.12%
-33,5
-31,7
-5.56%
-29,0
-33,7
14.05%
-13,8
-14,1
2.61%
-12,5
-13,7
8.35%






Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-33,4
-28,2
-18.35%
-35,0
-30,3
-15.39%
-38,3
-31,6
-21.31%
-28,0
-34,6
19.22%

-14,0

-11,9
-13,6
12.37%






Net income
Million EUR
Released
Forecast
Spread
-33,4
-28,2
-18.34%
-35,0
-30,3
-15.39%
-38,3
-31,6
-21.32%
-28,0
-34,6
19.21%

-14,0

-11,9
-13,6
12.37%
-1,02


-5,14


EPS
EUR
Released
Forecast
Spread
-18,6
-16,0
-16.25%
-19,5
-17,0
-14.71%
-20,4
-17,0
-20%
-12,2
-17,0
28.24%






-0,30





Announcement Date16/03/2021/09/2008/03/2120/09/2127/04/2212/05/2212/09/2221/11/22

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. PHXM Stock
  5. Calendar PHAXIAM Therapeutics S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW